terazosin 5 MG Oral Capsule
terazosin
RxCUI: 313219
What the CMS Formulary Data Shows for terazosin 5 MG Oral Capsule
Per the CMS 2026 Part D formulary file, terazosin 5 MG Oral Capsule (RxNorm concept RXCUI 313219, generic name terazosin) appears on 330 distinct formulary files spanning 5,067 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 1.1.
Real-world access to terazosin 5 MG Oral Capsule depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 26.1% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 339,977 Part D beneficiaries filled terazosin 5 MG Oral Capsule in 2023, with total plan-and-beneficiary spending of $39,888,387 and an average per-beneficiary annual cost of $117.33. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry terazosin 5 MG Oral Capsule today.
Coverage Details
- Formularies covering
- 330
- Plans covering
- 5,067
- Coverage rate
- 100%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 1, Preferred Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 26.1% of formularies
2023 Medicare Spending
- Beneficiaries
- 339,977
- Total spending
- $39,888,387
- Avg per beneficiary
- $117.33
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering terazosin 5 MG Oral Capsule
2 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| AARP Medicare Rx Preferred from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T1 | No | No | $0 | - |
| AARP Medicare Rx Preferred from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T1 | No | No | $0 | - |
Medicare Advantage Plans (MA-PD) Covering terazosin 5 MG Oral Capsule
98 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is terazosin 5 MG Oral Capsule covered by Medicare Part D?
Yes, terazosin 5 MG Oral Capsule is covered by 5,067 Medicare Part D plans (100% of all Part D formularies).
What tier is terazosin 5 MG Oral Capsule on Medicare Part D plans?
terazosin 5 MG Oral Capsule averages Tier 1.1 across Part D plans, ranging from Tier 1 to Tier 6.
Does terazosin 5 MG Oral Capsule require prior authorization?
0% of Part D formularies require prior authorization for terazosin 5 MG Oral Capsule. Step therapy: 0%. Quantity limits: 26.1%.
How much does Medicare spend on terazosin 5 MG Oral Capsule?
In 2023, total Medicare Part D spending on terazosin 5 MG Oral Capsule was $39,888,387, covering 339,977 beneficiaries. The average spend per beneficiary was $117.33.
Read our methodology - how this data is sourced, computed, and verified.